Vanguard Capital Management
WVE icon

Vanguard Capital Management’s Wave Life Sciences WVE Stock Holding History

Vanguard Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
1,751,403
+139,550
+9% +$925K ﹤0.01% 2801
2026
Q1 		$11.7M Buy
+1,611,853
New +$21M ﹤0.01% 2645

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Vanguard Capital Management's WVE Position: Q2 2026 in Review

Vanguard Capital Management increased its Wave Life Sciences (WVE) stake by 8.7% in Q2 2026, buying an estimated $925K and bringing the position to 1,751,403 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2801.

Vanguard Capital Management first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. The position peaked at $11.7M in Q1 2026. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Vanguard Capital Management held 1,751,403 shares of Wave Life Sciences worth $10.2M as of Q2 2026.
  • Vanguard Capital Management bought 139,550 Wave Life Sciences shares in Q2 2026, an estimated $925K.
  • Wave Life Sciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2801 holding.
  • Vanguard Capital Management first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Wave Life Sciences position peaked at $11.7M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.